311 related articles for article (PubMed ID: 18460483)
1. Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial.
Bloedon LT; Balikai S; Chittams J; Cunnane SC; Berlin JA; Rader DJ; Szapary PO
J Am Coll Nutr; 2008 Feb; 27(1):65-74. PubMed ID: 18460483
[TBL] [Abstract][Full Text] [Related]
2. Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low alpha-linolenic acid.
Prasad K; Mantha SV; Muir AD; Westcott ND
Atherosclerosis; 1998 Feb; 136(2):367-75. PubMed ID: 9543108
[TBL] [Abstract][Full Text] [Related]
3. Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects.
Goyens PL; Mensink RP
Eur J Clin Nutr; 2006 Aug; 60(8):978-84. PubMed ID: 16482073
[TBL] [Abstract][Full Text] [Related]
4. Flaxseed reduces total and LDL cholesterol concentrations in Native American postmenopausal women.
Patade A; Devareddy L; Lucas EA; Korlagunta K; Daggy BP; Arjmandi BH
J Womens Health (Larchmt); 2008 Apr; 17(3):355-66. PubMed ID: 18328014
[TBL] [Abstract][Full Text] [Related]
5. Effects of flaxseed consumption on systemic inflammation and serum lipid profile in hemodialysis patients with lipid abnormalities.
Khalatbari Soltani S; Jamaluddin R; Tabibi H; Mohd Yusof BN; Atabak S; Loh SP; Rahmani L
Hemodial Int; 2013 Apr; 17(2):275-81. PubMed ID: 22998533
[TBL] [Abstract][Full Text] [Related]
6. The effect of flaxseed dose on circulating concentrations of alpha-linolenic acid and secoisolariciresinol diglucoside derived enterolignans in young, healthy adults.
Edel AL; Patenaude AF; Richard MN; Dibrov E; Austria JA; Aukema HM; Pierce GN; Aliani M
Eur J Nutr; 2016 Mar; 55(2):651-663. PubMed ID: 25808116
[TBL] [Abstract][Full Text] [Related]
7. Flaxseed and cardiovascular risk.
Bloedon LT; Szapary PO
Nutr Rev; 2004 Jan; 62(1):18-27. PubMed ID: 14995053
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of the effects of flaxseed interventions on blood lipids.
Pan A; Yu D; Demark-Wahnefried W; Franco OH; Lin X
Am J Clin Nutr; 2009 Aug; 90(2):288-97. PubMed ID: 19515737
[TBL] [Abstract][Full Text] [Related]
9. Flaxseed and cardiovascular health.
Prasad K
J Cardiovasc Pharmacol; 2009 Nov; 54(5):369-77. PubMed ID: 19568181
[TBL] [Abstract][Full Text] [Related]
10. Flaxseed on cardiovascular disease markers in healthy menopausal women: a randomized, double-blind, placebo-controlled trial.
Dodin S; Cunnane SC; Mâsse B; Lemay A; Jacques H; Asselin G; Tremblay-Mercier J; Marc I; Lamarche B; Légaré F; Forest JC
Nutrition; 2008 Jan; 24(1):23-30. PubMed ID: 17981439
[TBL] [Abstract][Full Text] [Related]
11. Flaxseed lignan lowers blood cholesterol and decreases liver disease risk factors in moderately hypercholesterolemic men.
Fukumitsu S; Aida K; Shimizu H; Toyoda K
Nutr Res; 2010 Jul; 30(7):441-6. PubMed ID: 20797475
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, randomized, controlled trial of the effects of two eggs per day in moderately hypercholesterolemic and combined hyperlipidemic subjects taught the NCEP step I diet.
Knopp RH; Retzlaff BM; Walden CE; Dowdy AA; Tsunehara CH; Austin MA; Nguyen T
J Am Coll Nutr; 1997 Dec; 16(6):551-61. PubMed ID: 9430083
[TBL] [Abstract][Full Text] [Related]
13. Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.
Thomas GS; Cromwell WC; Ali S; Chin W; Flaim JD; Davidson M
J Am Coll Cardiol; 2013 Dec; 62(23):2178-84. PubMed ID: 24013058
[TBL] [Abstract][Full Text] [Related]
14. Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects.
Zhang W; Wang X; Liu Y; Tian H; Flickinger B; Empie MW; Sun SZ
Br J Nutr; 2008 Jun; 99(6):1301-9. PubMed ID: 18053310
[TBL] [Abstract][Full Text] [Related]
15. Effects of brown and golden flaxseed on the lipid profile, glycemia, inflammatory biomarkers, blood pressure and body composition in overweight adolescents.
Machado AM; de Paula H; Cardoso LD; Costa NM
Nutrition; 2015 Jan; 31(1):90-6. PubMed ID: 25441591
[TBL] [Abstract][Full Text] [Related]
16. Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women.
Lucas EA; Wild RD; Hammond LJ; Khalil DA; Juma S; Daggy BP; Stoecker BJ; Arjmandi BH
J Clin Endocrinol Metab; 2002 Apr; 87(4):1527-32. PubMed ID: 11932276
[TBL] [Abstract][Full Text] [Related]
17. Hazelnut-enriched diet improves cardiovascular risk biomarkers beyond a lipid-lowering effect in hypercholesterolemic subjects.
Orem A; Yucesan FB; Orem C; Akcan B; Kural BV; Alasalvar C; Shahidi F
J Clin Lipidol; 2013; 7(2):123-31. PubMed ID: 23415431
[TBL] [Abstract][Full Text] [Related]
18. Substitution of vegetable oil for a partially-hydrogenated fat favorably alters cardiovascular disease risk factors in moderately hypercholesterolemic postmenopausal women.
Vega-López S; Matthan NR; Ausman LM; Ai M; Otokozawa S; Schaefer EJ; Lichtenstein AH
Atherosclerosis; 2009 Nov; 207(1):208-12. PubMed ID: 19423109
[TBL] [Abstract][Full Text] [Related]
19. Lignan content of the flaxseed influences its biological effects in healthy men and women.
Almario RU; Karakas SE
J Am Coll Nutr; 2013; 32(3):194-9. PubMed ID: 23885993
[TBL] [Abstract][Full Text] [Related]
20. Flaxseed in pediatric hyperlipidemia: a placebo-controlled, blinded, randomized clinical trial of dietary flaxseed supplementation for children and adolescents with hypercholesterolemia.
Wong H; Chahal N; Manlhiot C; Niedra E; McCrindle BW
JAMA Pediatr; 2013 Aug; 167(8):708-13. PubMed ID: 23733031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
